CBI's Registries and Post-Approvals Studies Congress

Sep. 22, 2009-Sep. 24, 2009
Hyatt Regency Princeton
Princeton, NJ
www.cbinet.com/show_conference.cfm?confCode=PC09155

Description:

Clinical and Medical Affairs – Improving Communication in Post-Approval Studies

Keith Morris, Practice Executive, will present a session on successful communication strategies for effective execution of post-approval studies.

Abstract:

Unlike registrational studies, post-approval studies should be conducted with targeted commercial outcomes in mind. Successful targeting and execution of post-approval studies requires effective communication among Clinical Development, Medical Affairs, and commercial functions. While many organizations have historically struggled with this communication, it has become more important than ever as the government increases clinical trials requirements and pharmaceutical companies strive to be at the forefront of developing innovative life saving therapies. This session will examine the following:
 
  • Strategies for effective communication between Clinical Development and Medical Affairs in the development stage to support effective planning and continuity of studies throughout the product life cycle
  • Recommendations for successful communication between Medical Affairs and commercial to ensure effective targeting of post-approval studies
  • Approaches used by industry leaders to drive effective communication
 
 

View Entire Event Calendar

Don't Miss